Cambridge Investment Research Advisors Inc. Trims Stake in DaVita Inc. (NYSE:DVA)

Cambridge Investment Research Advisors Inc. trimmed its holdings in shares of DaVita Inc. (NYSE:DVA - Free Report) by 78.3% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3,043 shares of the company's stock after selling 10,982 shares during the quarter. Cambridge Investment Research Advisors Inc.'s holdings in DaVita were worth $465,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in DVA. UMB Bank n.a. boosted its holdings in shares of DaVita by 65.5% in the 1st quarter. UMB Bank n.a. now owns 192 shares of the company's stock worth $29,000 after purchasing an additional 76 shares in the last quarter. Copia Wealth Management purchased a new position in shares of DaVita in the 4th quarter worth about $30,000. Coppell Advisory Solutions LLC boosted its holdings in shares of DaVita by 50.0% in the 4th quarter. Coppell Advisory Solutions LLC now owns 300 shares of the company's stock worth $45,000 after purchasing an additional 100 shares in the last quarter. Canada Post Corp Registered Pension Plan purchased a new position in shares of DaVita in the 4th quarter worth about $55,000. Finally, Jones Financial Companies Lllp boosted its holdings in shares of DaVita by 28.6% in the 4th quarter. Jones Financial Companies Lllp now owns 517 shares of the company's stock worth $77,000 after purchasing an additional 115 shares in the last quarter. 90.12% of the stock is currently owned by hedge funds and other institutional investors.

DaVita Price Performance

Shares of DVA stock opened at $143.37 on Friday. The stock has a fifty day simple moving average of $140.21 and a two-hundred day simple moving average of $149.04. DaVita Inc. has a twelve month low of $131.76 and a twelve month high of $179.60. The stock has a market capitalization of $10.82 billion, a price-to-earnings ratio of 14.21, a P/E/G ratio of 0.98 and a beta of 1.11. The company has a current ratio of 1.25, a quick ratio of 1.20 and a debt-to-equity ratio of 23.18.

DaVita (NYSE:DVA - Get Free Report) last posted its earnings results on Monday, May 12th. The company reported $2.00 EPS for the quarter, topping the consensus estimate of $1.75 by $0.25. DaVita had a return on equity of 176.11% and a net margin of 6.63%. The firm had revenue of $3.22 billion for the quarter, compared to analyst estimates of $3.22 billion. During the same period last year, the company earned $2.26 earnings per share. DaVita's revenue for the quarter was up 5.0% compared to the same quarter last year. On average, analysts predict that DaVita Inc. will post 10.76 EPS for the current fiscal year.

Analyst Ratings Changes

DVA has been the subject of a number of recent analyst reports. Truist Financial lowered their price target on DaVita from $170.00 to $164.00 and set a "hold" rating for the company in a research report on Monday, May 19th. Wall Street Zen raised DaVita from a "hold" rating to a "buy" rating in a research report on Friday, April 25th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and two have assigned a buy rating to the company. According to MarketBeat, DaVita presently has an average rating of "Hold" and an average target price of $164.50.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.

Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DaVita Inc. (NYSE:DVA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.